DRUG APPROVALS

June 16, 2022

Introduction to Two Recently Approved Insulin Glargine Biosimilars

Two insulin biosimilars for insulin glargine, a subcutaneous long-acting insulin analogue for improving glycemic control, have recently been approved
October 15, 2021

Review of Selected NMEs 2021

October 15, 2021

New Drug Review 2021

October 16, 2020

New Drug Review 2020

October 16, 2019

Review of Selected NMEs 2019

October 16, 2019

New Drug Review 2019

October 16, 2018

Review of Selected NMEs 2018

October 16, 2018

New Drug Review 2018

October 13, 2017

New Drug Review 2017